Our study aims to synthesize current knowledge on the roles of IL-6 and TNF-alpha in ischemic stroke, explore their potential as biomarkers for disease progression and prognosis, and correlate the degree of disability in ischemic stroke patients with plasma concentrations of these two biomarkers. This evidence concerns the gene IL6 and ischemic stroke.